New York, New Jersey Clinical Trials

A listing of New York, New Jersey clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 425 clinical trials
Phase 2 Study of SAR439859 Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer (AMEERA-3)

Primary Objective: To determine whether SAR439859 per os improves progression free survival (PFS) when compared with a endocrine monotherapy of the choice of the physician, in participants with metastatic or locally advanced breast cancer. Secondary Objectives: To compare the overall survival in the 2 treatment arms To assess the objective …

cancer
estrogen
hormone therapy
exemestane
estrogen receptor-positive breast cancer
Investigational Site Number 8400025
 (7.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +130 other locations
Aging and Information Processing

The purpose of our study is to better understand functional differences in brain activity between healthy aging and neurodegenerative conditions, such as Alzheimer's Disease. To do this, our lab uses a noninvasive and inexpensive technique to collect brain measurements called electroencephalogram (EEG). By recording EEG while participants do certain memory …

AutoSite12071
 (5.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +8 other locations
Formal Test Trial 500 Site & User

Test comment here

A123
 (4.2 away) Contact site
  • 0 views
  • 09 Jul, 2026
  • +1 other locations
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis (FREVIVA)  

The purpose of this randomized, double-blind, placebo-controlled, parallel group study is to determine the efficacy of frexalimab in delaying the disability progression and the safety up to approximately 51 months administration of study intervention compared to placebo in male and female participants with nrSPMS (aged 18 to 60 years at …

Holy Name Medical Center Site Number : 8400101
 (7.2 away)
  • 0 views
  • 04 Mar, 2025
  • +58 other locations
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma (AIRLYMPUS)

This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma.The purpose of this study is to assess the efficacy, safety, and tolerability of add-on therapy with SC lunsekimig compared with placebo in male and female participants (aged 18 to 80 years, inclusive) with asthma, …

Icahn School of Medicine at Mount Sinai - Mount Sinai Health System- Site Number : 8400069
 (3.6 away) Contact site
  • 0 views
  • 24 Nov, 2025
  • +50 other locations
Efficacy of Buprenorphine for Treatment of Acute Pain  

The purpose of this study is to determine whether sublingual buprenorphine is effective in the treatment of acute pain in adult patients with extremity bone fractures

acute pain
morphine
buprenorphine
xxxx@test.com
 (5.2 away)
  • 0 views
  • 20 Sep, 2024
  • +12 other locations
CW Non-featured Trials

Test non-featured trials

Site1
 (3.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Not featured111111  

Version4

Site
 (4.1 away)
  • 0 views
  • 19 Feb, 2024
  • 1 location
PRAGMA (Prostate Radio Ablation Guided by Magnetic Resonance Imaging Acquisition) in Metastatic Prostate Cancer

Patients with metastatic prostate cancer can undergo MRI-guided prostate Stereotactic body radiation therapy (SBRT) without significant adverse events, similar to what has been reported for patients with localized prostate cancer. We hypothesize that prostate SBRT will be well-tolerated in metastatic prostate cancer patients, with quality of life outcomes similar to …

cancer
non-metastatic prostate cancer
adenocarcinoma
stereotactic body radiation therapy
MRI
Weill Cornell Medicine
 (3.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Multinational Randomized Double-blind Placebo-controlled Study to Assess the Efficacy Pharmacodynamics Pharmacokinetics and Safety of Venglustat in Late-onset GM2

Primary Objectives: Primary population (adult participants with late-onset GM2 gangliosidosis): To assess the efficacy and pharmacodynamics (PD) of daily oral dosing of venglustat when administered over a 104-week period Secondary population (participants with juvenile/adolescent late-onset GM2 gangliosidosis, GM1 gangliosidosis, saposin C deficiency, sialidosis type 1 or juvenile/adult galactosialidosis): To assess …

Investigational Site Number 8400001
 (3.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations